Announcements Trials

Browse Landscape

Phase

Phase 2 5 Phase EARLY_PHASE1 4 Phase NA 3 Phase 1/2 2 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Heart Failure 1 Cardiotoxicity 1

Interventions

Dexamethasone 56 Metformin 50 Cyclophosphamide 47 Saline Solution 39 Cytarabine 37 Cisplatin 36 Zoledronic Acid 34 Letrozole 34 Carboplatin 33 Sodium Chloride 32 Bupivacaine 31 Docetaxel 30 Bevacizumab 30 Vincristine 29 Methotrexate 29 Fluorouracil 28 Propofol 27 Capecitabine 27 Fentanyl 26 Doxorubicin 26 Rituximab 25 Drug Therapy 25 Dexmedetomidine 25 Prednisone 23 Paclitaxel 23 Oxaliplatin 21 Morphine 21 Gemcitabine 21 Radiotherapy 19 Prednisolone 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Interventional × Spironolactone × Clear all

NCT06005259 2023-08-22

SPIROTOX

University of Sao Paulo

Phase 4 Unknown

Heart Failure, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡